Diagnostic and treatment methods in patients having or at risk of developing resistance to cancer therapy
作者： Levi A. Garraway , Cory M. Johannessen
DOI:
关键词: Combination therapy 、 Cancer therapy 、 HDAC inhibitor 、 MAPK/ERK pathway 、 In patient 、 Cancer 、 MEK inhibitor 、 Pharmacology 、 Medicine 、 Treatment method
摘要: A method of identifying a subject having cancer who is likely to benefit from treatment with combination therapy MAPK pathway inhibitor, such as RAF MEK or ERK and GEF HDAC inhibitor provided. treating in need thereof also provided includes administering the an effective amount inhibitor. targets that confers resistance
lens.org参考文章(185)
Shaoqing Chen, Steven Gregory Mischke, Nicholas John Silvester Huby, Norman Kong, Hong Wang, Zhuming Zhang, John Anthony Moliterni, Hydantoin based kinase inhibitors ,(2007)
John Sondek, Rafael Rojas, Methods for identifying chemical modulators of Ras superfamily GTPase activity ,(2005)
Sean V. Tavtigian, Mark H. Skolnick, William L. Perry, David H. F. Teng, Specific mutations of map kinase 4 (MKK4) in human tumor cell lines identify it as a tumor suppressor in various types of cancer Official Gazette of the United States Patent and Trademark Office Patents. ,(1997)
Chau D Pham, Ralph B Arlinghaus, Chao-Feng Zheng, Kun-Liang Guan, Balraj Singh, None, Characterization of MEK1 phosphorylation by the v-Mos protein. Oncogene. ,vol. 10, pp. 1683- 1688 ,(1995)
Richard Anthony Storey, Mohammed Pervez, Ronald John Roberts, Christopher John Squire, Tosylate salt of 6- (4-br0m0-2-chl0r0phenylamin0) -7-fluoro-n- (2-hydroxyethoxy) -3-methyl-3h-benzimi dazole- 5 - carboxamide , mek inhibitor useful in the treatment of cancer ,(2006)
Yongqi Deng, Mehul Patel, Hugh Zhu, Hon-Chung Tsui, Neng-Yang Shih, Sunil Paliwal, Abdul-Basit Alhassan, Ronald Doll, Jagdish Desai, Gerald W. Shipps, Xiaolei Gao, Joseph Kelly, James Wang, Liang Zhu, Yang Nan, Sobhana Babu Boga, Alan Cooper, Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer ,(2008)
Haile Tecle, David Thomas Dudley, Alexander James Bridges, Annette Marian Doherty, Stephen Douglas Barrett, Alan Robert Saltiel, 4-brom or 4-iod-phenylamino-benzhydroxamsäurederivate und ihre anwendung als mek-inhibitoren ,(1998)
Kevin Michael Foote, Keith Hopkinson Gibson, Laurent Francois Andre Hennequin, Pharmaceutical compositions comprising benzofuranyl substituted 3-cyanoquinoline derivatives and their use for the treatment of solid tumours ,(2002)
Hong Liu, Quing Weng, Neal C. Birnberg, John Kyriakis, Joseph Avruch, Xanthene compounds for cancer chemotherapy ,(2003)
David C Heimbrook, Deborah L Zink, Allen I Oliff, Gerald F Bills, Leeyuan Huang, Hans E Huber, Fernando Pelaez, Rosalind G Jenkins, Anne W Dombrowski, Seok H Lee, Otto D Hensens, Annie Z Zhao, Dolores Vilella, Maria Teresa Diez, Denis R Patrick, Michael A Goetz, Richard L Kendall, Nicole D Falconi, Jr Kenneth A Thomas, Marina Mojena, MEK inhibiting lactones ,(1998)